![Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study | BMC Gastroenterology | Full Text Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-022-02388-6/MediaObjects/12876_2022_2388_Fig3_HTML.png)
Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study | BMC Gastroenterology | Full Text
![Therapeutic Retention Enemas: An Underutilized Modality for UC – Naturopathic Doctor News and Review Therapeutic Retention Enemas: An Underutilized Modality for UC – Naturopathic Doctor News and Review](https://ndnr.com/wp-content/uploads/2016/01/28072819_ml.jpg)
Therapeutic Retention Enemas: An Underutilized Modality for UC – Naturopathic Doctor News and Review
PUBLIC ASSESSMENT REPORT of the Medicines Evaluation Board in the Netherlands Budenofalk Schuim 2 mg, rectal foam Dr. Falk Pharm
![Full article: Real-world safety and efficacy of twice-daily budesonide 2-mg foam in patients with ulcerative colitis: interim analysis of post-marketing surveillance Full article: Real-world safety and efficacy of twice-daily budesonide 2-mg foam in patients with ulcerative colitis: interim analysis of post-marketing surveillance](https://www.tandfonline.com/cms/asset/ec7ac79e-1ded-42e3-95ae-639c4726110a/ieop_a_1905796_f0001_b.gif)
Full article: Real-world safety and efficacy of twice-daily budesonide 2-mg foam in patients with ulcerative colitis: interim analysis of post-marketing surveillance
![PDF] Making Education Easy Budesonide [ Budenofalk ® ] foam enema for the treatment of active rectal and rectosigmoid disease in ulcerative colitis PRODUCT | Semantic Scholar PDF] Making Education Easy Budesonide [ Budenofalk ® ] foam enema for the treatment of active rectal and rectosigmoid disease in ulcerative colitis PRODUCT | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9f3b4f80c3224d76b8388be744777dbc1e37cc35/4-Table2-1.png)
PDF] Making Education Easy Budesonide [ Budenofalk ® ] foam enema for the treatment of active rectal and rectosigmoid disease in ulcerative colitis PRODUCT | Semantic Scholar
![Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis - ScienceDirect Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508515001547-gr3.jpg)
Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis - ScienceDirect
![Ulcerative Colitis Treatment“RECTABUL® 2 mg Rectal Foam 14 Doses” Launches in Japan | Investors(2017) | EA Pharma Co., Ltd. Ulcerative Colitis Treatment“RECTABUL® 2 mg Rectal Foam 14 Doses” Launches in Japan | Investors(2017) | EA Pharma Co., Ltd.](https://www.eapharma.co.jp/sites/default/files/corporate_files/en_news/2017/images/1206.png)